149 related articles for article (PubMed ID: 6255060)
1. [Carcinoma of the rhinopharynx in France, and the Epstein-Barr virus. Presence of Epstein-Barr nuclear antigen in tumor tissue].
Seigneurin JM; Junien-Lavillauroy C; Roux O; Bolla M; Kressmann MC; Couderc P
J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1980 Oct; 29(8):535-8, 541-4. PubMed ID: 6255060
[No Abstract] [Full Text] [Related]
2. [Nasopharyngeal carcinoma and the Epstein-Barr virus].
Boger-Goren S; Gotlieb-Stematsky T
Harefuah; 1985 May; 108(10):514-6. PubMed ID: 2995214
[No Abstract] [Full Text] [Related]
3. [Value of Epstein-Barr virus serology during radiotherapy of undifferentiated carcinoma of the nasopharynx].
Yomi J; Fouda A; Fossi A; Bejanga B
Bull Cancer Radiother; 1996; 83(3):168-9. PubMed ID: 8977568
[No Abstract] [Full Text] [Related]
4. Anticomplement immunoenzymatic method of detecting Epstein-Barr nuclear antigen in nasopharyngeal carcinoma cells and normal epithelial cells.
Zeng Y; Shen SJ; Pi GH; Ma JL; Zhang Q; Zhao ML; Dong HJ
Chin Med J (Engl); 1981 Oct; 94(10):663-8. PubMed ID: 6274591
[No Abstract] [Full Text] [Related]
5. [An enhancing effect in the expression of Epstein-Barr virus specific antigen by implantation of nasopharyngeal carcinoma cells into nude mouse].
Furukawa M; Ohoka H; Ikeda C; Nishimura T; Umeda R
Nihon Jibiinkoka Gakkai Kaiho; 1988 Jan; 91(1):49-55. PubMed ID: 2455026
[No Abstract] [Full Text] [Related]
6. [A specific histological marker of undifferentiated carcinoma of the nasopharynx. The ACIF (Anti-Complement Immunofluorescence) test].
Micheau C; De The G; Schwaab G; Tursz T; Sancho-Garnier H; Montagu B
Ann Pathol; 1984; 4(2):143-6. PubMed ID: 6329239
[TBL] [Abstract][Full Text] [Related]
7. [Value of anti-Epstein-Barr antibody detection in the diagnosis and management of undifferentiated carcinoma of the nasopharynx].
Mazeron MC
Bull Cancer Radiother; 1996; 83(1):3-7. PubMed ID: 8679277
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus-determined nuclear antigen in malignant epithelial cells of nasopharyngeal carcinoma.
Suzuki T; Katano A; Oboshi S; Sairenji T; Hinuma Y
Gan; 1978 Feb; 69(1):133-8. PubMed ID: 205477
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between natural cytotoxicity activity, Epstein-Barr virus (EBV) antibody titer and clinical status in nasopharyngeal carcinoma patients].
Mu M
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1988; 23(1):46-9. PubMed ID: 2856431
[No Abstract] [Full Text] [Related]
10. [Epstein-Barr virus nuclear antigen (EBNA) assay of the puncture smears from neck masses for the differential diagnosis of nasopharyngeal carcinoma].
Chen QB
Zhonghua Zhong Liu Za Zhi; 1985 Jan; 7(1):29-30. PubMed ID: 2983959
[No Abstract] [Full Text] [Related]
11. Nasopharyngeal carcinoma and Epstein-Barr virus. I. Factors related to the anti-VCA antibody.
Lynn T; Tu S; Hirayama T; Kawamura A
Jpn J Exp Med; 1973 Apr; 43(2):121-33. PubMed ID: 4352111
[No Abstract] [Full Text] [Related]
12. [Malignant lymphoma of the nasopharynx of non-Burkitt's type--a case report of a patient with positive Epstein-Barr virus-associated nuclear antigen (EBNA) (author's transl)].
Takimoto T; Morishita K; Kawanaka T; Ishikawa S; Furukawa M; Miyazaki T
Nihon Jibiinkoka Gakkai Kaiho; 1982 Feb; 85(2):145-50. PubMed ID: 6283047
[No Abstract] [Full Text] [Related]
13. Early nasopharyngeal carcinoma among IgA/VCA antibody positive individuals detected by anticomplement immunoenzymatic method.
Zeng Y; Shen SJ; Deng H; Ma JL; Zhang Q; Zhu JS; Cheng JR
Chin Med J (Engl); 1984 Mar; 97(3):155-7. PubMed ID: 6088182
[No Abstract] [Full Text] [Related]
14. Epstein-Barr virus-associated antigens in nasopharyngeal carcinoma.
Coates HL; Pearson GR; Neel HB; Weiland LH
Arch Otolaryngol; 1978 Aug; 104(8):427-30. PubMed ID: 209772
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus-related lymphocyte stimulation inhibitor: a possible prognostic tool for undifferentiated nasopharyngeal carcinoma.
Kamaraju LS; Levine PH; Sundar SK; Ablashi DV; Faggioni A; Armstrong GR; Bertram G; Krueger GR
J Natl Cancer Inst; 1983 Apr; 70(4):643-7. PubMed ID: 6300502
[TBL] [Abstract][Full Text] [Related]
16. [Epstein-Barr virus--a clinically relevant feature of nasopharyngeal carcinoma? (author's transl)].
Wilmes E; Wolf H; Deinhardt F; Naumann HH
Laryngol Rhinol Otol (Stuttg); 1981 Jan; 60(1):4-6. PubMed ID: 6261051
[TBL] [Abstract][Full Text] [Related]
17. [The value of polymerase chain reaction on Epstein-Barr virus subtypes in the differentiation of benign and malignant nasopharyngeal biopsies].
Sun N; Chen X
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995; 30(4):213-5. PubMed ID: 8745459
[TBL] [Abstract][Full Text] [Related]
18. Studies on nasopharyngeal carcinoma in Thailand.
Premabutr P; Thomson S; Srivatanakul P
J Med Assoc Thai; 1974 Apr; 57(4):191-6. PubMed ID: 4377011
[No Abstract] [Full Text] [Related]
19. Serum responses to the combination of Epstein-Barr virus antigens from both latent and acute phases in nasopharyngeal carcinoma: complementary test of EBNA-1 with EA-D.
Chow KC; Ma J; Lin LS; Chi KH; Yen SH; Liu SM; Liu WT; Chen WK; Chang TH; Chen KY
Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):363-8. PubMed ID: 9149897
[TBL] [Abstract][Full Text] [Related]
20. Epstein-barr-virus nuclear antigen.
Vonka V; Hirsch I
Prog Med Virol; 1982; 28():145-79. PubMed ID: 6283600
[No Abstract] [Full Text] [Related]
[Next] [New Search]
